GSK Investigational Site

Kirchheim unter Teck 73230

0 studies enrolling now · 4 studies all time

What they study most

Churg-Strauss Syndrome, Giant Cell Arteritis, Hypereosinophilic Syndrome, Vasculitis

Studies at this site

• A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 — Completed
• Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis — Stopped early
• Belimumab in Remission of VASculitis — Completed
• A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis — Completed